Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Conflicting perspectives during guidelines development are an important source of implementation failure

22 May 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Michaels et al. described the challenges surrounding the implementation of evidence-based clinical guidelines developed by national authorities and organizations. The authors examined the conflicts (objectives, values, and preferences) between stakeholders that develop and those that should implement clinical guidelines by analysing the situation at the National Institute of Health and Care Excellence (NICE) in England. Furthermore, the authors discussed the implications of these conflicts and provided recommendations for implementing guidelines effectively.

Access the full-text article here.